Panel Discussion: Concurrent Modalities in Cannabinoid Therapeutics: Advances in Synthetic & Botanical Drug Development
- Navigating the differences in the regulatory landscape for botanical and synthetic drugs
- Discussing how research into both fields has contributed to the overall understanding of cannabinoid pharmacology
- Validating effectively scaling up in synthetic drug production versus maintaining API consistency in botanical drugs